ABSTRACT BACKGROUND
myelogenous leukemia. If the lymphoid cells predominate, the disease is termed lymphocytic leukemia. These are associated with varied systemic involvement such as anemia, splenomegaly, generalised lymphadenopathy and petechial haemorrhagic spots. In 2010, globally, approximately 281,500 people died of leukemia [1] . In 2000, approximately 256,000 children and adults around the world developed a form of leukemia, and 209,000 died from it [2] .
Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells or blasts. Leukemias are classified into two broad groups, if myelocytic cells or other cells derived from the CFU-GEMM (Colony forming unit-Granulocytic, Erythrocytic, Monocytic, Megakaryocytic) stem cell predominate, the disease is called This represents about 3% of the almost seven million deaths due to cancer that year, and about 0.35% of all deaths from any cause [2] . For this reason, the clinician also requires the basic peripheral blood smear study as a preliminary examination to differentiate the various diseases that overlap the symptomatology of acute leukemia clinically. Diagnosing the type and sub-type of leukemia is very important as the therapy, prognosis and survival rate changes with each type and sub-type. Less than 15% of cases in children below 10years, 25-30% between 10-15 years, and 80-90% of adults cases of acute myeloid leukaemia (AML) [3] . ALL constitutes over 80% of childhood cases and comprises of 12% of all leukemias [4] . The MIC (Morphology, Immunohistochemistry, and cytogenetics) classification incorporates leukemic cellular morphology, immunohistochemistry (IHC) and cytogenetics as three important criteria for the classification of leukemias [5] . Chromosomal abnormalities are important for the classification and diagnosis of the disorder. In acute leukemias, the karyotype may be an important and independent prognostic factor in predicting both remission achievement and the length of remission and in distinguishing potential long term survivors from those likely to fail on standard therapy [5] . Immunophenotyping by flow cytometry which detects the cell surface antigens is used to diagnose and classify acute leukemia as in some cases of AML lacking cytochemical staining(AML FAB M0) or identification of subtypes that have a different prognosis (B cell ALL) or require an alternate therapeutic regimen (AML FAB M3) [6] . The combined evaluation of leukemias by morphology, cytogenetics and immunophenotyping is very important for an accurate diagnosis and for planning the treatment. Hence the present study is being conducted to diagnose and classify the type and subtype of leukemias by a combination of the above parameters. ration with Life Line Diagnostics, Hyderabad. Bone marrow aspirate and peripheral blood smear samples from patients of all age groups who present with abnormal haematological findings suggestive of leukaemia, presenting with hepatosplenomegaly &lymphadenopathy, investigated for pyrexia of unknown origin, complaining of bone pain. Patients who drop out of the study before complete work-up, due to death or discharge against advice have been excluded from the study. The relevant clinical history was obtained in each case, routine blood counts performed and peripheral smears studied in detail. About 0.5 -1ml of bone marrow sample was collected from each case in EDTA and heparinized tubes. Smears from EDTA samples were stained with standard Romanowsky stain (Leishman stain) and studied for morphology of cells. The Cytochemical stains with Myeloperoxidase Stain (MPO) and Periodic Acid Schiff Stain (PAS) was done in all cases for preliminary typing of leukaemia. Bone marrow culture for cytogenetic analysis: About 2-4 drops of heparinised (sodium heparin) marrow was added to 2 culture tubes, each containing 8 ml of RPMI-1640 medium supplemented with 20% fetal bovine serum. No mitotic stimulants were used. One culture was incubated at 37c for 24 hrs and the other at 37c for 48hrs. After 24 or 48 hrs of incubation, 50 ml of colcenoid (10µg/ml) was added to the culture to arrest the cell division at metaphase stage, Culture was incubated for further 30 minutes, Except 0.5ml, all supernatant was discarded, The cells were subjected to hypotonic treatment with 5 ml of 0.075 Potassium chlorides with constant agitation, Cultures were incubated for 15 min at 37ºC and centrifuged at 1500 revolutions per minute for 3 minutes, The supernatant was discarded and freshly prepared fixative (Methanol: acetic acid in the ratio 3:1) was added drop by drop with constant agitation. This step was repeated thrice. The final concentration of cell suspension was adjusted visually after preparing and examining the test slide. Precleaned slide with ethyl alcohol was taken and a layer of fixative was run over it. 1 drop of cell suspension was dropped on to the wet slide from a height of 4-6 inches and air dried. The slides were incubated at 65ºover night before
MATERIALS AND METHODS
The study was done from August 2010 to September 2012.Peripheral blood and bone marrow aspirate samples received at the Department of Pathology, Kakatiya Medical College, and Warangal were studied in collabo-
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GTG-banding. GTG Banding (G-banding using Trypsin and Giemsa stain): Coplin jar 1: Trypsin working solution: 50 ml of normal saline (NS) was added to 5 mg of trypsin powder, mixed well and allowed to stand for 10 minutes at room temperature. Coplin jar2:50 ml of NS. Coplin jar 3: To 42 ml of distilled water, 2.5 ml each of sodium dihydrogen phosphate and Disodium hypophosphate solutions were added and to this, 3 ml of water soluble Giemsa stain solution added, mixed well and the top layer removed using a filter paper. Coplin jar 4: 50 ml of distilled water. Slides incubated at 65 were dipped in trypsin working solution (coplin jar 1) for 20-35 seconds. Slides were briefly rinsed in coplin jar 2 (NS). Slides were stained with buffered Giemsa (Coplin jar 3) for 10 min. Slides were rinsed in distilled water (coplin jar 4) briefly, air dried. Banded slides were mounted with cover slips using DPX mountant. Thus GTG banding was done on these slides, and chromosomes analyzed. At least 20 metaphases were screened for structural and numerical abnormalities, and atleast 5 metaphases were karyotyped. Karyotypes were described according to the International System for Chromosomal Nomenclature (ISCN). Table 5 : Diagnosis on cytochemistry. T-Cell 3
B-Cell 12

Mixed lineage 1
No of cases done 25
Total case 36 B-lymphoblastic leukaemia/lymphoma with hypodiploidy 0 0%
T-lymphoblastic leukaemia 3 8.30%
Mixed phenotypic acute leukaemia,T/Myeloid NOS 1 2.70%
Total
100%
DISCUSSION with the study done by Ghosh et al [8] with AML-M2 being the commonest subtype in adults (32%) and also in children (42%). MPO and PAS stain was done on all 36 cases of acute leukaemias and 20 (55.5%) out of these showed positivity favouring the diagnosis of AML, and 7(19.5%) of these showed positivity for PAS favouring a diagnosis of ALL. Cytochemistry is performed in all 36 cases, which helped in differentiating lymphoid and myeloid leukaemias. MPO and PAS stain was performed in all 36 cases, out of which 20 cases showed MPO positivity and 7 cases showed PAS positivity. Comparison of value of Immunophenotyping in diagnosis of acute leukaemia by flow cytometry, a study by Xiao et al (10) In the present study 36 cases of leukaemia were evaluated by morphology, cytochemistry, Immunophenotyping, cytogenetics, FISH to arrive at a final diagnosis. The duration of study was from August 2010 to September 2012. 63.8% of cases were males and 36.2% were females, the male female ratio being1 76:1 were participated in this study. Different types of leukaemias have different clinical presentations. In this study the most common clinical presentation of patients was fever followed by splenomegaly. Lymphadenopathy was the clinical presentation in children with ALL. The study of Koushal et al [7] found splenomegaly as the commonest presentation (81%) followed by hepatomegaly (69%) and fever (61%). In the study done by Ghosh et al [8] pallor and weakness were the commonest clinical findings (82%) followed by lymphadenopathy (36.2%).
In the present study the majority of cases were AML (20 cases) followed by ALL (15 cases) and 1 case of mixed lineage acute leukaemia. Vinsheeth et al (9) in their study found CML as the commonest leukaemia (110 cases) followed by AML (18) and ALL (10) . Present study is almost in concordance with other studies except for higher no of AML cases which could be due to population bias. In this study out of 20 cases of AML, AML-M2 with 4 cases was the commonest followed by M3 with 3 cases. This is in league and 1 of the cases culture failed. The variation in the accuracy of ALL diagnosed by cytogenetics in our study is probably due to slightly dilute BM samples got mostly from the paediatric age group. Some of these cases showed normal karyotype and hence accurate sub typing was not possible in these cases. In this study chromosomal abnormalities were present in 10 cases out of 36 cases (28%) while Charrin et al [11] found chromosomal abnormalities in 378 out of 443 cases (85%). And in the study done by Koushal et al [7] 8 cases out of 26 cases had chromosomal abnormalities (31%). Detection of chromosomal abnormalities depends on multiple factors like, type of leukaemia, percentage of blasts in the sample, technical experts in the culture preparation and banding.
CONCLUSION
Leukemia or leukaemia is a type of cancer of the blood or bone marrow, the incidence of various types of leukaemias varies considerably in different age groups, racial and ethnic differences too. There may be population bias, which leads to variation in the prevalence of different types of leukaemias. Out of 36 blood and bone marrow samples studied, a final diagnosis was given after correlating morphology, cytochemistry. This is helping for classification and treatment of leukaemias. Hence we conclude that in identifying the lineage specificity of various types of leukaemias and helps on arriving at a final diagnosis especially in cases with ambiguous morphology on peripheral blood smear and bone marrow examination.
